Literature DB >> 11528202

Methods for measuring crystallization in urolithiasis research: why, how and when?

B Hess1, R L Ryall, J P Kavanagh, S R Khan, D J Kok, A L Rodgers, H G Tiselius.   

Abstract

Whereas crystalluria does not distinguish between kidney stone formers and healthy people and thus can be considered a physiologic event, kidney stone formation is a pathologic incident and reflects a specific form of biomineralization. Both single urinary crystals as well as whole kidney stones form under exquisite control of organic macromolecules. Simple crystal formation in the urinary tract is distinguished from stone formation in the kidney by the process of particle retention. The latter occurs either because nucleated crystals strongly aggregate to particles too large to pass freely through the tubules ('free particle' theory), or because crystals become abnormally adherent to tubular cell surfaces ('fixed particle' theory). Since it is impossible to mimic all the processes involved in stone formation in vitro, it is highly important to carefully chose a specific crystallization process for in vitro studies, and to select the most appropriate experimental conditions for measuring the chosen process as reliably as possible. This overview aims at critically reviewing the principles of currently available assay systems for studying crystallization processes involved in stone formation. Consensus is reached by the experts that no in vitro system really mimics what happens in renal stone formation, but that carefully designed in vitro studies will always play an important part in urolithiasis research. For such studies, it is highly important to exactly control the appropriate experimental conditions that are relevant to a specific crystallization process under investigation. Practical guidelines for researchers working with crystallization systems are provided, and it is concluded that international efforts should be made to standardize the terminology, to agree on a set of basic experimental parameters (temperature, pH, artificial urine composition), and to adopt simple tests or conditions are reference points for quality and comparative control.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11528202     DOI: 10.1159/000049776

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  10 in total

1.  A stone farm: development of a method for simultaneous production of multiple calcium oxalate stones in vitro.

Authors:  K Chow; J Dixon; S Gilpin; J P Kavanagh; P N Rao
Journal:  Urol Res       Date:  2003-10-22

Review 2.  In vitro calcium oxalate crystallisation methods.

Authors:  John P Kavanagh
Journal:  Urol Res       Date:  2006-01-14

3.  Protective impact of resveratrol in experimental rat model of hyperoxaluria.

Authors:  Taylan Oksay; Sedat Yunusoğlu; Mustafa Calapoğlu; I Aydın Candan; İbrahim Onaran; Osman Ergün; Alper Özorak
Journal:  Int Urol Nephrol       Date:  2017-02-09       Impact factor: 2.370

4.  Potential thermodynamic and kinetic roles of phytate as an inhibitor of kidney stone formation: theoretical modelling and crystallization experiments.

Authors:  Saajidah Fakier; Allen Rodgers; Graham Jackson
Journal:  Urolithiasis       Date:  2019-02-14       Impact factor: 3.436

5.  Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis.

Authors:  Steeve Doizi; Kathy Rodgers; John Poindexter; Khashayar Sakhaee; Naim M Maalouf
Journal:  J Urol       Date:  2015-12-23       Impact factor: 7.450

6.  Face-specific incorporation of osteopontin into urinary and inorganic calcium oxalate monohydrate and dihydrate crystals.

Authors:  Lauren A Thurgood; Alison F Cook; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2010-07-22

7.  How do stones form? Is unification of theories on stone formation possible?

Authors:  Victoria Y Bird; Saeed R Khan
Journal:  Arch Esp Urol       Date:  2017-01       Impact factor: 0.436

8.  The effect of hydrodynamic and thermodynamic factors and the addition of citric acid on the precipitation of calcium oxalate dihydrate.

Authors:  Anamarija Šter; Silvija Šafranko; Katarina Bilić; Berislav Marković; Damir Kralj
Journal:  Urolithiasis       Date:  2017-06-23       Impact factor: 3.436

Review 9.  [Calcium oxalate stones and hyperoxaluria. What is certain? What is new?].

Authors:  M Straub; R E Hautmann; A Hesse; L Rinnab
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

10.  Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals.

Authors:  Alison F Cook; Phulwinder K Grover; Rosemary L Ryall
Journal:  BJU Int       Date:  2008-11-13       Impact factor: 5.588

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.